Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery

NCT00758199 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

49

Enrollment

NETWORK

Sponsor class

Conditions

Cataracts

Interventions

DRUG: Bromfenac
DRUG: Moxifloxacin hydrochloride
DRUG: Prednisolone Acetate

Sponsor

Bp Consulting, Inc